We are now starting to release the videos from our July conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, which was hosted in NYC at Cooper Union. Today, we show Dr. Aubrey de Grey giving his keynote speech at the conference. He begins, as all good speakers should, in a mixed audience of experienced…
As our organization grows and we are doing more and more things, there is an ever greater need for specialist knowledge and guidance to help inform our decisions as a company. We rely on the advice and expertize of both our scientific and business advisors and we have added to them this week with two…
The AgeMeter project hosted on Lifespan.io last year is almost ready to start shipping, the team informs us that units will begin going out to backers starting from September 4th. In addition, you can also learn more about the AgeMeter functional aging biomarker system at the AgeMeter website, they are also taking preorders for the…
Today, we were pleased to hear that Samumed, a San Diego-based biotech company working on regenerative medicine, has just raised $438 million towards developing anti-aging therapies. SAN DIEGO – August 6, 2018 – Samumed, LLC, announced today that it has closed its A-6 Round of equity issuance with $438 million, bringing its total equity raised…
Today, we wanted to draw your attention to a review of aging and the role that the gut microbiome plays in it. There is an increasing amount of evidence for the contribution of microbial burden in the chronic, age-related background of inflammation known as “inflammaging“. There are a number of proposed sources of inflammaging, including…
This is part of our ongoing series of articles that discuss the Hallmarks of Aging. Published in 2013, the paper divides aging into distinct categories (“hallmarks”) of damage to explain how the aging process works and how it causes age-related diseases. Today, we will be looking at the hallmark of cellular senescence. What are senescent…
Today, we are pleased to announce that the results are in from a human trial that targets the aging immune system and that an immune system-boosting drug appears to be effective. Targeting TORC1 to boost the immune system As we age, the immune system becomes increasingly poor and unable to detect and fight infections. This…
Australian researchers have made a discovery about telomeres that may have implications for aging, heart disease, cancer, and other age-related diseases. So, what are telomeres? Each of the chromosomes that store our genetic information has a telomere at each end. This protective cap consists of a specific DNA sequence that is repeated thousands of times…
A common concern in the community is that the FDA, the EMA, and other bodies, such as WHO, do not classify aging as a disease and that this poses a problem for developing therapies that target aging. However, this is not really as serious an issue as some people would suggest; today, we will have…
On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. We are delighted to announce that the conference was a huge success with 160 attendees, a wide variety of speakers…